Hematology/Oncology
RSSArticles
-
Critical Care Alert October 2011 Issue in PDF
-
Pharmacology Watch: Apixaban is Heating Up the Anticoagulation Market
In this issue: Apixaban could soon join the anticoagulation market; Chinese herbs for flu; chronic medication and discontinuation after hospitalization; and FDA actions. -
Special Feature: Pregnancy and Critical Care Medicine — Part 1I: Acute Respiratory Failure and Pregnancy
In Part 1 of this two-part series on Pregnancy and Critical Care Medicine (see Critical Care Alert, March 2011, p. 89-93), we reviewed the normal physiologic changes that occur during pregnancy, examining changes occurring across multiple organ systems that affect our management of these patients as well as the ability of the pregnant woman to respond to various forms of stress, such as acute hemorrhage. -
Clinical Briefs in Primary Care supplement
-
Abstract & Commentary: Patient Outcomes After Failed Extubation
In this prospective study carried out in a 13-bed French medical ICU, Thille and associates sought to determine the clinical characteristics and outcomes of patients who experienced extubation failure the requirement for reintubation within 72 hours of either planned or unplanned extubation. -
Primary Care Reports - Full September 2011 Issue in PDF
-
Innovative Antidepressant Newcomers: Suitability in Primary Care
Clinical depression is highly prevalent in the general population and in primary care settings. Although clinicians presently have a broad array of pharmacological agents for the treatment of depression, including selective serotonin reuptake inhibitors and serotonin norepinephrine reuptake inhibitors, overall response rates and remission rates with these pharmacological agents remain relatively modest. -
Special Feature: PEEP for One and PEEP for All
Would you like to start a fight? Just ask a colleague how he or she selected the level of positive end-expiratory pressure (PEEP) for a patient. -
Pharmacology Watch: ACEIs and ARBs Help Patients with Aortic Stenosis
In this issue: ACEI/ARB therapy for AS; safety alert issued for dronedarone; statins and cancer risk; nesiritide and heart failure; and FDA actions. -
Critical Care Alert September 2011 Issue in PDF